Regarding organ outcomes, our review indicates that, in high-risk populations, GLP-1RAs are associated with a 12-15% relative risk reduction in MACE and favorable effects on composite renal endpoints
In just two years, the number of Chinese API manufacturers for Semaglutide jumped from 4 to 33 now representing ~80% of the global supply base
Second, in the CY 2025 PFS final rule (89 FR 98266), CMS stated that the purpose of providing additional data elements not explicitly listed in sections 1847A(i)(1)(A)(i) through (iii) of the Act (for example, the payment amount in the payment amount benchmark quarter, specified amounts, and certain unit data) is based on CMS' assessment of data elements are necessary [for a manufacturer] to review the Preliminary Report for a Suggestion of Error. Providing these data in the Preliminary Rebate Report (and corresponding subsequent reports) ensures that: (1) manufacturers will be able to submit a Suggestion of Error, thereby promoting ( accuracy in the implementation of the rebate program
PRP costs range from $285 to $500+ per injection in Canada, with some injuries requiring multiple sessions
10.1016/j.pbb.2012.08.017 66 IslamA.IslamMd S.RahmanMd K.UddinMd N.AkandaMd R
